#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Splenic marginal zone lymphoma Paraganglion neoplasm Pulmonary hypertension Chemical burn B precursor type acute leukaemia Non-Hodgkin's lymphoma unspecified histology indolent Neuroendocrine carcinoma Barth syndrome Selective polysaccharide antibody deficiency Mucous membrane pemphigoid Cutaneous T-cell lymphoma Glioma Wiskott-Aldrich syndrome Loeys-Dietz syndrome Chorioretinitis More trials…

    Learn about Rare Diseases

    Retinoblastoma – Trials in Disease Rhabdomyosarcoma – Diagnostics Bronchopulmonary dysplasia – Life with Disease Hairy cell leukaemia – Treatment Hereditary hypophosphataemic rickets – Basic Information Idiopathic pulmonary fibrosis – Diagnostics Angiosarcoma – Trials in Disease Tuberous sclerosis complex – Life with Disease Pemphigus – Life with Disease Mucopolysaccharidosis III – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bbp-398 Bgb-15025 Citrate SULBACTAM SODIUM Ecoo6A Ifezuntirgene Inilparvovec Efruxifermin Azd8630 Resiquimod Sulfate Caffeine Tasimelteon Carbetocin Nicotinamide Bp Tub-040 Posdinemab Azelastine STREPTOCOCCUS PYOGENES Voriconazole Ipatasertib NADOFARAGENE FIRADENOVEC Specific Nucleic Acid Sna-Ebv More therapies…

    Learn about Your Condition

    Invasive breast carcinoma High-grade B-cell lymphoma Synovitis Chronic spontaneous urticaria Systemic lupus erythematosus Oesophageal achalasia Castleman's disease Arthralgia Eyelid ptosis Brain injury Hypotransferrinaemia Rabies Staphylococcal bacteraemia Peripheral ischaemia Diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • A study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Chloride
    Belgium France Germany Italy The Netherlands Spain

  • Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

    Recruiting

    2 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Cenegermin
    Denmark Finland France Germany Italy Poland +2

  • A study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Frexalimab
    Belgium Italy Spain

  • A study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ublituximab
    Poland

  • A study to evaluate the safety of VTx-002 in patients with amyotrophic lateral sclerosis.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Sodium Dihydrogen Phosphate Dihydrate
    • VTX-002
    Belgium The Netherlands Spain

  • Study of intranasal insulin to prevent delirium in patients aged 65 years or older following elective cardiac surgery

    Recruiting

    4 1 1
    Investigated Diseases:
    • Delirium
    Investigated Drugs:
    • Sodium Chloride
    • Insulin Human
    The Netherlands
Previous Page
1 2 3 4 5 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!